Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon

Wrist wearable uses pulses to relieve chronic motion sickness

Chronic motion sickness patients could be helped by the Reliefband, a wearable that uses pulses to block signals entering the part of the brain related to nausea. 

Gates to invest $100M in dementia, Alzheimer's initiatives

IBM founder Bill Gates has a new target for his renowned philanthropic endeavors. The billionaire announced Nov. 13 that he will donate nearly $100 million to projects focused on researching dementia and Alzheimer's disease.

Thumbnail

Trump nominates Azar, former pharma exec, to lead HHS

On Monday morning, President Donald Trump announced the nomination of Alex Azar to lead HHS. A former executive for pharmaceutical giant Eli Lilly, he has long been a frontrunner to replace Tom Price, who stepped down in September after criticism for using expensive chartered flights.

AMA Honors Former AAOS CEO with a Lifetime Achievement Award

HONOLULU – During the opening session of its 2017 Interim Meeting, the American Medical Association (AMA) presented Karen L. Hackett, FACHE, CAE, former chief executive officer of the American Academy of Orthopaedic Surgeons (AAOS), with the Medical Executive Lifetime Achievement Award. This award honors a medical association executive who has contributed substantially to the goals and ideals of the medical profession.

GOP plan to eliminate medical expense deductions spooks patients

The tax reform bill introduced by Republicans in the U.S. House last week included a provision that could be bad news for patients receiving bad news. The GOP proposal eliminates the ability for individuals to itemize their federal income taxes to deduct medical expenses that exceed 10 percent of their total income.

Thumbnail

Final MACRA rule too strict for some, too loose for others: ‘Do we need MIPS at all?’

While the proposed rule for the second year of the Medicare Access and CHIP Reauthorization Act (MACRA)’s Quality Payment Program (QPP) earned mostly praise from the healthcare industry, the finalized rule earned a mixed reaction from groups alternating saying it’ll burden providers and it’s allowing too many physicians to avoid the program altogether.

Thumbnail

AI coaching app assists at-risk patients in preventing type 2 diabetes

As the number of individuals with type 2 diabetes increases, researchers search for a way to prevent or slow the progression of diabetes in at-risk patients. According to a study published in JMIR Diabetes, an artificial intelligence (AI) coaching platform could improve habits to prevent the onset of type 2 diabetes.

AHIP elects new board members

Nine new members have been added to the board of directors of America’s Health Insurance Plans (AHIP), including executives from three Blue Cross Blue Shield plans and Tampa-based WellCare Health Plans.

Displaying 4057 - 4064 of 6652

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup